Session Synopsis: Our lives and our practices are quickly adapting to the impacts of new trends in mobile health. These trends are breaking down barriers and integrating virtual services within the primary care clinic, leading to advantages such as cost reduction, clinical efficacy, care for the elderly, and access to digital health data that patients and consumers can use to improve their health.
Session Chair Profile
Ph.D., Senior Vice President, Informatics, Takeda Pharmaceuticals and Visiting Scientist in Biomedical Informatics Institution, Harvard Medical School
Eric Perakslis is a research, informatics, technology and R&D leader with more than 19 years of direct experience in information technology, informatics, research, healthcare, government regulation, biotechnology and pharmaceuticals discovery and development. He received his PhD in Chemical and Biochemical Engineering from Drexel University. Following a stint with ArQule, Inc., he joined the Johnson and Johnson companies, serving first as Director of Drug Discovery Global Information Solutions, NA at RWJ Pharmaceutical Research and progressing to Vice President R&D Informatics at Centocor and Member of the J&J Corporate Office of Science and Technology and ultimately to Sr Vice President, CIO at J&J Pharma R&D and Head of Translational Informatics at J&J Corporate Office of Science and Development. Perakslis became CIO and Chief Scientist (Informatics) at the FDA in 2011 before moving to HMS to serve as Executive Director at the Center for Biomedical Informatics. He currently is Senior VP, R&D Informatics at Takeda Pharmaceuticals International Inc. in Cambridge, MA.
Strategies for Delivering Value from Digital Technology Transformation
Many organizations are attempting to harness emerging digital technologies and the surge in the amount of health-related data to drive advances in the development and use of medicines. Focusing on just a few well-proven and readily available strategies could enable such organizations to quickly realize greater value from data and digital technologies.
M.D., Ph.D., MSPH, Physician Executive for Clinical Strategy, Cerner Corporation
Dr. John David Larkin Nolen provides clinical strategic guidance for Cerner Corporation’s solutions in precision medicine, laboratory medicine, behavioral health, and long-term post-acute care. Using his clinical knowledge, analytical skills and engineering talents, he is positioning Cerner’s solutions and clients for the future of medicine. He represents Cerner on boards, working groups, and standards organizations, including HL7, IHE, DICOM, IOM, AMIA, and CLSI. Dr. Nolen joined Cerner in 2010 as the Director of Laboratory Strategy. Since then, he has been instrumental in guiding the incorporation of new solutions around genomics, automation, and technologies into Cerner solutions. He transitioned to the Managing Director of the laboratory business unit in 2013, and expanded his clinical strategic responsibilities in 2015 to solutions beyond laboratory medicine.
The Role of Interoperability of Patient Data in Precision Medicine
The emergence of the SMART on FHIR platform has ushered in a new landscape of interoperability for healthcare IT. It is enabling precision medicine by knocking down barriers and legacy paradigms to make the healthcare IT landscape flat and let the data flow. This talk will cover the current state of the precision medicine landscape from an IT perspective and highlight where things are headed.